Ofuchi Takashi, Otsu Hajime, Hosoda Kiyotaka, Ikehara Tomohiko, Tsujimoto Akinori, Higuchi Satoshi, Shibuta Shohei, Ono Yuya, Hirose Kosuke, Tsuda Yasuo, Yonemura Yusuke, Masuda Takaaki, Hayashi Hiromitsu, Iwatsuki Masaaki, Mimori Koshi
Department of Surgery, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Beppu Oita, 874-0838, Japan.
Department of Gastroenterological Surgery, Graduate School of Medicine, Kumamoto University, Kumamoto, Japan.
J Gastroenterol. 2025 Jun 20. doi: 10.1007/s00535-025-02278-0.
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with poor prognosis, which is often driven by chromosomal amplifications at 1q. Vacuolar sorting protein 45 (VPS45), a gene located on chromosome 1q, is involved in the endocytic recycling pathway; however, its role in HCC remains unclear. In this study, we aimed to investigate the functional significance of VPS45 in the progression of HCC.
VPS45 expression was analyzed using public databases, clinical HCC samples, and cell lines. Functional assays, including VPS45 knockout and rescue experiments, were conducted to assess the effect on tumor progression in vitro and in vivo. The molecular mechanisms underlying VPS45 function, particularly its role in β1 integrin recycling and FAK-AKT signaling activation, were also explored.
VPS45 expression was significantly elevated in HCC owing to DNA copy number amplification and correlated with poor prognosis. Moreover, VPS45 knockout suppressed cell proliferation, migration, and invasion, while promoting apoptosis. VPS45 interacted with syntaxin16 and rabenosyn-5 to facilitate the recycling of β1 integrin to the cell membrane, thereby activating FAK-AKT signaling, which promotes oncogenic phenotypes. In xenograft models, VPS45 knockout significantly suppressed tumor growth, further supporting its role in HCC progression.
VPS45 is a key oncogene in HCC that promotes tumor progression by enhancing β1 integrin recycling and activating FAK-AKT signaling. Given its strong association with poor prognosis and tumor malignancy, VPS45 may serve as a promising prognostic biomarker and a potential therapeutic target for HCC.
肝细胞癌(HCC)是一种侵袭性很强且预后较差的恶性肿瘤,常由1q染色体的扩增驱动。液泡分选蛋白45(VPS45)是位于1q染色体上的一个基因,参与内吞再循环途径;然而,其在HCC中的作用仍不清楚。在本研究中,我们旨在探讨VPS45在HCC进展中的功能意义。
使用公共数据库、临床HCC样本和细胞系分析VPS45的表达。进行了包括VPS45基因敲除和挽救实验在内的功能测定,以评估其对体外和体内肿瘤进展的影响。还探索了VPS45功能的分子机制,特别是其在β1整合素再循环和FAK-AKT信号激活中的作用。
由于DNA拷贝数扩增,VPS45在HCC中的表达显著升高,且与预后不良相关。此外,VPS45基因敲除抑制细胞增殖、迁移和侵袭,同时促进细胞凋亡。VPS45与 syntaxin16和rabynosyn-5相互作用,促进β1整合素循环至细胞膜,从而激活FAK-AKT信号,促进致癌表型。在异种移植模型中,VPS45基因敲除显著抑制肿瘤生长,进一步支持其在HCC进展中的作用。
VPS45是HCC中的关键癌基因,通过增强β1整合素再循环和激活FAK-AKT信号促进肿瘤进展。鉴于其与预后不良和肿瘤恶性程度密切相关,VPS45可能是一种有前景的预后生物标志物和HCC的潜在治疗靶点。